Investigation of Heart Failure Status Over Time Using Respiratory Parameters
Completed
- Conditions
- Heart Failure, CongestiveSleep Apnea Syndromes
- Registration Number
- NCT00494117
- Lead Sponsor
- ResMed
- Brief Summary
The purpose of the study is to investigate respiratory indicators for clinically important changes in Heart Failure status over time.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Moderate to severe Heart Failure (as determined by Echocardiogram or by treating physician)
Exclusion Criteria
- Malignant disease affecting gas exchange or respiratory parameters
- Medications compromising breathing with no adverse affects on heart failure
- Clinically significant (moderate to severe) asthma requiring therapy
- Chronic parenchymal lung disease (FEV1/FVC ratio = 65% or as determined by the treating physician)
- Severe pulmonary hypertension
- Heart failure due to alcohol abuse or chemotherapy
- Narcotic abuse/intravenous drug use (including HIV+ and hepatitis C)
- Alcohol consumption > 80g/day
- Patients receiving home Oxygen
- Methicillin- resistant Staphylococcus aureus infection
- Narcolepsy
- Cataplexy
- Enrolled in any concurrent study, that may confound the results of this study.
- Inability or refusal to sign the Patient Consent Form
- Inability or refusal to adhere to protocol requirements
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What respiratory biomarkers correlate with heart failure progression in NCT00494117?
How do sleep apnea severity metrics relate to heart failure outcomes in observational studies?
What molecular mechanisms link respiratory function to congestive heart failure status changes?
Are there comparative effectiveness studies of ResMed's respiratory monitoring vs. standard HF management?
Which biomarkers predict response to respiratory parameter-based heart failure monitoring strategies?
Trial Locations
- Locations (1)
Royal Prince Alfred Hospital
🇦🇺Camperdown, New South Wales, Australia
Royal Prince Alfred Hospital🇦🇺Camperdown, New South Wales, Australia